Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors

European Journal of Pharmacology - Tập 427 - Trang 187-193 - 2001
Michael S Lidow1, Amy Roberts1, Ling Zhang1, Phil-Ok Koh1, Nelson Lezcano2, Clare Bergson2
1Department of Oral and Craniofacial Biological Sciences and Program in Neuroscience, University of Maryland, 5-A-12, HHH 666 W. Baltimore St. Baltimore, MD, 21201, USA
2Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912 USA

Tài liệu tham khảo

Assie, 1999, Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity, Eur. J. Pharmacol., 386, 97, 10.1016/S0014-2999(99)00738-4 Birnbaumer, 1990, Receptor–effector coupling by G proteins, Biochim. Biophys. Acta, 1031, 163, 10.1016/0304-4157(90)90007-Y Childers, 1993, BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells, Mol. Pharmacol., 44, 827 Creese, 1979, 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors, Eur. J. Pharmacol., 56, 411, 10.1016/0014-2999(79)90274-7 De Keyser, 1988, D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation, Brain Res., 443, 77, 10.1016/0006-8993(88)91600-9 Di Salvo, 2000, The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Gα1-coupled and uncoupled states, Eur. J. Pharmacol., 409, 143, 10.1016/S0014-2999(00)00846-3 Ferre, 1993, Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes, Eur. J. Pharmacol., 244, 311, 10.1016/0922-4106(93)90157-5 Gurevich, 1997, Agonist–receptor–arrestin, an alternative ternary complex with high agonist affinity, J. Biol. Chem., 272, 28849, 10.1074/jbc.272.46.28849 Hall, 1999, Heptahelical receptor signaling: beyond the G protein paradigm, J. Cell. Biol., 145, 927, 10.1083/jcb.145.5.927 Hamm, 1998, The many faces of G protein signaling, J. Biol. Chem., 273, 669, 10.1074/jbc.273.2.669 Heidenrich, 1980, Characterization of radiolabeled agonist binding to β-adrenergic receptors in mammalian tissues, J. Cyclic Nucleotide Res., 6, 271 Hess, 1986, Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum, Eur. J. Pharmacol., 121, 31, 10.1016/0014-2999(86)90389-4 Johnson, 1994, Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure–activity relationship of certain ergolines and tryptamines, Mol. Pharmacol., 45, 277 Kent, 1980, A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data, Mol. Pharmacol., 17, 14 Lezcano, 2000, Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein, Science, 287, 1660, 10.1126/science.287.5458.1660 Oldenhof, 1998, SH3 binding domains in the dopamine D4 receptor, Biochemistry, 37, 1526, 10.1021/bi981634+ Perez, 1996, Constitutive activation of a single effector pathway: evidence for multiple activation states of G protein-coupled receptor, Mol. Pharmacol., 49, 112 Roth, 1997, High affinity agonist binding is not sufficient for agonist efficacy at 5-hydrohytriptamine-2A receptors: evidence in favor of a modified ternary complex model, J. Pharmacol. Exp. Ther., 280, 576 Schulz, 1985, Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP, J. Neurochem., 45, 1601, 10.1111/j.1471-4159.1985.tb07233.x Seifert, 1998, Different effects of Gsα splice variants on β2-adrenoreceptor-mediated signaling, J. Biol. Chem., 273, 5109, 10.1074/jbc.273.9.5109 Titeler, 1979, Selective labeling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine, Eur. J. Pharmacol., 56, 291, 10.1016/0014-2999(79)90187-0 Urwyler, 1987, Affinity shift induced by cations do not reliably predict the agonistic or antagonistic nature of ligands at brain dopamine receptors, J. Neurochem., 49, 1415, 10.1111/j.1471-4159.1987.tb01008.x Van Rampelbergh, 1996, Mol. Pharmacol., 50, 1596 Waelbroeck, 1999, Kinetics versus equilibrium: the importance of GTP in GPCR activation, Trends Pharmacol. Sci., 20, 477, 10.1016/S0165-6147(99)01394-2 Wang, 1997, Ribozyme-mediated suppression of the G protein γ7 subunit suggests a role in hormone regulation of adenylyl cyclase activity, J. Biol. Chem., 272, 26040, 10.1074/jbc.272.41.26040